SARS-CoV-2 neutralizing capacity among blood donors without prior COVID-19 symptomatic history vs. blood donors with prior COVID-19 symptomatic history: A comparative study

INTRODUCTION: Though moderate to severely ill COVID-19 patients are being treated using COVID Convalescent plasma across the world, there is a lack of standardization or information about the relative neutralizing capacity of antibodies from convalescent plasma donors. The current study aimed to com...

Descripción completa

Detalles Bibliográficos
Autores principales: Ravula, Ushasree., Chunchu, Srinivasa Rao, Mooli, Srujaleswari, Naik, Ravi, Sarangapati, Pandu Ranga Rao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société française de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8839806/
https://www.ncbi.nlm.nih.gov/pubmed/35167958
http://dx.doi.org/10.1016/j.tracli.2022.02.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8839806/
https://www.ncbi.nlm.nih.gov/pubmed/35167958
http://dx.doi.org/10.1016/j.tracli.2022.02.004

Ejemplares similares